ABSTRACT
【Objective】 To observe the clinical effects of syringo-pleural shunt as a supplementary in the treatment of syringomyelia. 【Methods】 Eleven patients with syringomyelia were treated with syringo-pleural shunt from December 2017 to December 2019. Tator’s postoperative evaluation standard was used to determine the clinical effects of improvement of clinical symptoms. MRI and the Japanese Orthopedic Association (JOA) score were used to evaluate the improvement of syringomyelia and neurological function. 【Results】 After 3 months, 6 months and 12 months of follow-up, the clinical symptoms and JOA score improved in 10 cases, and 1 case had no improvement and developed severe pleural effusion. MRI showed that syringomyelia was significantly improved in 10 cases, and there was no improvement in 1 case. 【Conclusion】 Syringo-pleural shunt is a safe, direct and effective supplementary treatment method for patients with syringomyelia.